Skip to content
Recall Observatory FDA recall evidence

Device product

The Access Cortisol assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of cortisol levels in human serum, plasma (heparin, EDTA) and urine using the Access Immunoassay Systems.

Z-0313-2025

September 30, 2024

Class II

Product summary

Firm
Beckman Coulter, Inc.
Event
Event 95473
Status
Ongoing
Classification
Class II
Quantity
149 units
Official record key
device-enforcement:Z-0313-2025

Official wording

Reason: The Access Cortisol assay protocol file (APF) applies an incorrect calibration curve acceptance parameter at the S1 calibrator level that can lead to a high rate of calibration failures which can vary by reagent lot number. Calibration failure would lead to delay of measurement results reporting and potential injuries.

Code information: UDI/DI 15099590231118, all lots

Distribution pattern: Worldwide distribution.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    The Access Cortisol assay protocol file (APF) applies an incorrect calibration curve acceptance parameter at the S1 calibrator level that can lead to a high rate of calibration failures which can vary by reagent lot number. Calibration failure would lead to delay of measurement results reporting and potential injuries.

Field note

Send feedback

We'll only use this to respond to your feedback.